Clinical Trial Update: AI-Enhanced Wide-Field Endoscopic Fluorescence Mapping of Gastrointestinal Mucosal Permeability in IBD - A Pilot Study in IBD Patients and Controls

View source ↗

Summary

This pilot clinical trial examines AI-enhanced wide-field endoscopic fluorescence mapping to evaluate gastrointestinal mucosal permeability in inflammatory bowe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Ulcerative Colitis

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Inflammatory Bowel Disease (Crohn's Disease; Ulcerative Colitis), NON-IBD | Status: NOT_YET_RECRUITING